A Study of SGN-STNV in Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Suzanne McGoldrick, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Ottawa / Ottawa General Hospital
Ottawa, Ontario, Canada
- University Health Network, Princess Margaret Hospital
Toronto, Other, Canada
- Institut Gustave Roussy
Villejuif, Other, France
- Istituto Europeo Di Oncologia
Milan, Other, Italy
- Hospital Universitari Vall D'Hebron
Barcelona, Other, Spain
- the Royal Marsden Hospital (surrey)
Sutton, Other, United Kingdom
- the Angeles Clinic and Research Institute
Los Angeles, California, United States
- University of California, San Francisco | Hdfccc - Hematopoietic Malignancies
San Francisco, California, United States
- Shands Cancer Center / University of Florida
Gainesville, Florida, United States
- University of Miami
Miami, Florida, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- South Texas Accelerated Research Therapeutics Midwest
Grand Rapids, Michigan, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Magee Womens Hospital of Upmc
Pittsburgh, Pennsylvania, United States
- South Texas Accelerated Research Therapeutics
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jan 2021
- Primary completion
- 1 Mar 2024
- Completion
- 1 Mar 2024
- Last update posted
- 7 Feb 2025
- Registered enrollment
- 111
- Registry id
- NCT04665921
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.